ClinicalTrials HQ

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Active, not recruiting · NCT04314531 · Registry updated 2026-03-10
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)Active Psoriatic ArthritisActive, not recruitingPhase 32026-03-10NCT04314531

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Sun Pharmaceutical Industries Limited16

49 results · Page 1 of 2

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Sunpharma Site 100MadridSpain1
Sunpharma Site 106LucknowIndia1
Sunpharma Site 107BelagaviIndia1
Sunpharma Site 108PuneIndia1
Sunpharma Site 109HubliIndia1
Sunpharma Site 110BangaloreIndia1
Sunpharma Site 111SuratIndia1
Sunpharma Site 112HyderabadIndia1
Sunpharma Site 113KochiIndia1
Sunpharma Site 18IncheonSouth Korea1
Sunpharma Site 19SeoulSouth Korea1
Sunpharma Site 20SeoulSouth Korea1
Sunpharma Site 22Kitakyushu-shiJapan1
Sunpharma Site 23TsuJapan1
Sunpharma Site 24MiyazakiJapan1
Sunpharma Site 39PhillipAustralia1
Sunpharma Site 63ZlínCzechia1
Sunpharma Site 64BrnoCzechia1
Sunpharma Site 71CórdobaSpain1
Sunpharma Site 72SevilleSpain1
Sunpharma Site 73BerlinGermany1
Sunpharma Site 74PoznanPoland1
Sunpharma Site 75A CoruñaSpain1
Sunpharma Site 84NagoyaJapan1
Sunpharma Site 85ShinjukuJapan1